The role of dimerisation in the cellular trafficking of G-protein-coupled receptors.
暂无分享,去创建一个
[1] G. Milligan. A day in the life of a G protein‐coupled receptor: the contribution to function of G protein‐coupled receptor dimerization , 2008, British journal of pharmacology.
[2] P. Sexton,et al. Pattern of Intra-Family Hetero-Oligomerization Involving the G-Protein-Coupled Secretin Receptor , 2008, Journal of Molecular Neuroscience.
[3] U. Petäjä-Repo,et al. Opioid Receptor Pharmacological Chaperones Act by Binding and Stabilizing Newly Synthesized Receptors in the Endoplasmic Reticulum* , 2007, Journal of Biological Chemistry.
[4] Ruben Abagyan,et al. Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor , 2009, Molecular Pharmacology.
[5] K. Ressler,et al. Specificity of Olfactory Receptor Interactions with Other G Protein-coupled Receptors* , 2007, Journal of Biological Chemistry.
[6] K. Minneman,et al. Heterodimerization and surface localization of G protein coupled receptors. , 2007, Biochemical pharmacology.
[7] Pierre-Alexandre Vidi,et al. Adenosine A2A receptors assemble into higher‐order oligomers at the plasma membrane , 2008, FEBS letters.
[8] L. Miller,et al. Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor* , 2007, Journal of Biological Chemistry.
[9] Graeme Milligan,et al. The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities* , 2005, Journal of Biological Chemistry.
[10] Guangyu Wu,et al. Anterograde Trafficking of G Protein-Coupled Receptors: Function of the C-Terminal F(X)6LL Motif in Export from the Endoplasmic Reticulum , 2009, Molecular Pharmacology.
[11] Richard N. Zare,et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.
[12] G. Hendy,et al. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly. , 2006, Human molecular genetics.
[13] C. Hague,et al. Heterodimerization with β2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of α1D-Adrenergic Receptors , 2005, Journal of Pharmacology and Experimental Therapeutics.
[14] J. Mazurkiewicz,et al. Serotonin 5-HT2C Receptor Homodimer Biogenesis in the Endoplasmic Reticulum , 2006, Journal of Biological Chemistry.
[15] L. Devi,et al. Cell surface targeting of μ-δ opioid receptor heterodimers by RTP4 , 2008, Proceedings of the National Academy of Sciences.
[16] Pierre-Alexandre Vidi,et al. Fluorescent and Bioluminescent Protein-Fragment Complementation Assays in the Study of G Protein-Coupled Receptor Oligomerization and Signaling , 2009, Molecular Pharmacology.
[17] J. Galzi,et al. Pirenzepine Promotes the Dimerization of Muscarinic M1 Receptors through a Three-step Binding Process* , 2009, The Journal of Biological Chemistry.
[18] M. Robitaille,et al. A Single Conserved Leucine Residue on the First Intracellular Loop Regulates ER Export of G Protein‐Coupled Receptors , 2009, Traffic.
[19] H. Kaneko,et al. A highly conserved tryptophan residue in the fourth transmembrane domain of the A1 adenosine receptor is essential for ligand binding but not receptor homodimerization , 2009, Journal of neurochemistry.
[20] B. O'dowd,et al. Agonist-Induced Cell Surface Trafficking of an Intracellularly Sequestered D1 Dopamine Receptor Homo-Oligomer , 2006, Molecular Pharmacology.
[21] L. Miller,et al. Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor. , 2008, Biochimica et biophysica acta.
[22] S. Marullo,et al. An escort for GPCRs: implications for regulation of receptor density at the cell surface. , 2008, Trends in pharmacological sciences.
[23] Guangyu Wu,et al. Regulation of G protein-coupled receptor export trafficking. , 2007, Biochimica et biophysica acta.
[24] T. Streichert,et al. Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization. , 2009, Biochemical and biophysical research communications.
[25] A. Penn,et al. Molecular determinants of AMPA receptor subunit assembly , 2007, Trends in Neurosciences.
[26] C. Goudet,et al. Allosteric functioning of dimeric class C G‐protein‐coupled receptors , 2005, The FEBS journal.
[27] G. Milligan,et al. Chapter 10. Hetero-oligomerization of chemokine receptors. , 2009, Methods in enzymology.
[28] G. Milligan,et al. High-affinity interactions between human α1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the α1L-adrenoceptor , 2004 .
[29] R. A. Hall,et al. Enhancement of the surface expression of G protein-coupled receptors. , 2009, Trends in biotechnology.
[30] C. Combs,et al. Dimerization of CXCR 4 in living malignant cells : control of cell migration by a synthetic peptide that reduces homologous CXCR 4 interactions , 2006 .
[31] Jean-François Mercier,et al. Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting* , 2004, Journal of Biological Chemistry.
[32] T. Hébert,et al. Bioluminescence Resonance Energy Transfer Studies Reveal Constitutive Dimerization of the Human Lutropin Receptor and a Lack of Correlation between Receptor Activation and the Propensity for Dimerization* , 2009, Journal of Biological Chemistry.
[33] A. Chattopadhyay,et al. Are specific nonannular cholesterol binding sites present in G-protein coupled receptors? , 2009, Biochimica et biophysica acta.
[34] T. Walther,et al. Lack of Evidence for AT1R/B2R Heterodimerization in COS-7, HEK293, and NIH3T3 Cells , 2009, Journal of Biological Chemistry.
[35] Michel Bouvier,et al. Methods to monitor the quaternary structure of G protein‐coupled receptors , 2005, The FEBS journal.
[36] E. Martínez-Alonso,et al. Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. , 2006, The Journal of investigative dermatology.
[37] P. Conn,et al. Drug development and the cellular quality control system. , 2009, Trends in pharmacological sciences.
[38] O. Lichtarge,et al. Functional Rescue of β1‐Adrenoceptor Dimerization and Trafficking by Pharmacological Chaperones , 2009, Traffic.
[39] Graeme Milligan,et al. Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta2-adrenoceptor. , 2007, Cellular signalling.
[40] Guangyu Wu,et al. Cell-surface targeting of alpha2-adrenergic receptors -- inhibition by a transport deficient mutant through dimerization. , 2006, Cellular signalling.
[41] J. Konopka,et al. Identification of amino acids at two dimer interface regions of the alpha-factor receptor (Ste2). , 2009, Biochemistry.
[42] M. Robitaille,et al. Seven Transmembrane Receptor Core Signaling Complexes Are Assembled Prior to Plasma Membrane Trafficking* , 2006, Journal of Biological Chemistry.
[43] M. Robitaille,et al. Intracellular trafficking and assembly of specific Kir3 channel/G protein complexes. , 2009, Cellular signalling.
[44] Graeme Milligan,et al. G protein-coupled receptor dimerisation: molecular basis and relevance to function. , 2007, Biochimica et biophysica acta.
[45] D. Sibley,et al. D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin* , 2007, Journal of Biological Chemistry.
[46] Adam J Kuszak,et al. Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. , 2009, The Journal of biological chemistry.
[47] Irina S. Moreira,et al. Allosteric communication between protomers of dopamine Class A GPCR dimers modulates activation , 2009, Nature chemical biology.
[48] Bruno Antonny,et al. The apparent cooperativity of some GPCRs does not necessarily imply dimerization. , 2009, Trends in pharmacological sciences.
[49] P. Conn,et al. Targeting of G protein-coupled receptors to the plasma membrane in health and disease. , 2009, Frontiers in bioscience.
[50] Graeme Milligan,et al. The α1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function , 2007, Molecular Pharmacology.
[51] G. Milligan,et al. Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective α1b-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers , 2008, The Biochemical journal.
[52] N. Tinel,et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization , 2008, Nature Methods.
[53] C. Combs,et al. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions , 2006, Molecular Cancer Therapeutics.